Journal Home > Volume 12 , Issue 6

Taxifolin loaded zein-caseinate nanoparticles (TZP) were fabricated by the anti-solvent method and were used as an oral delivery vehicle to improve their bioavailability in the rat. The formulations of TZP were optimized. With mass ratio of 1:1:2 between taxifolin, zein and sodium caseinate, the particle size and ζ-potential of TZP were (168.74 ± 0.35) nm and (−57.67 ± 0.25) mV, while the encapsulation and loading efficiency of taxifolin were (85.83 ± 0.89)% and (17.11 ± 0.88)%, respectively. After freeze-drying, TZP exhibited excellent redispersibility in water without aggregation. Physicochemical characterization showed that taxifolin existed in amorphous form in TZP and its interaction with the protein was observed. After encapsulating in TZP, the excellent dispersion of taxifolin in water significantly improve its diffusion velocity through a semi-permeable membrane. After oral administration, taxifolin and its five metabolites were identified in rat plasma by ultra high performance liquid chromatography (UPLC) with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). The dynamic variation of taxifolin and its metabolites in plasma were then quantified by UPLC with a triple-quadrupole typemass spectroscopy (UPLC-QqQ-MS/MS). A pharmacokinetic study showed that the bioavailability of taxifolin increased from 0.35% to 0.52% through TZP fabrication. The plasma concentration of taxifolin glucuronide and methylated taxifolin glucuronide was much higher than taxifolin. Glucuronidation was the dominating metabolism pathway of taxifolin in vivo.


menu
Abstract
Full text
Outline
About this article

Fabrication of taxifolin loaded zein-caseinate nanoparticles and its bioavailability in rat

Show Author's information Ying LiaHang SuaWenjun WangaZhongping YinaJing'en LiaEn YuanbQingfeng Zhanga( )
Jiangxi Key Laboratory of Natural Product and Functional Food, College of Food Science and Engineering, Jiangxi Agricultural University, Nanchang 330045, China
College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

Taxifolin loaded zein-caseinate nanoparticles (TZP) were fabricated by the anti-solvent method and were used as an oral delivery vehicle to improve their bioavailability in the rat. The formulations of TZP were optimized. With mass ratio of 1:1:2 between taxifolin, zein and sodium caseinate, the particle size and ζ-potential of TZP were (168.74 ± 0.35) nm and (−57.67 ± 0.25) mV, while the encapsulation and loading efficiency of taxifolin were (85.83 ± 0.89)% and (17.11 ± 0.88)%, respectively. After freeze-drying, TZP exhibited excellent redispersibility in water without aggregation. Physicochemical characterization showed that taxifolin existed in amorphous form in TZP and its interaction with the protein was observed. After encapsulating in TZP, the excellent dispersion of taxifolin in water significantly improve its diffusion velocity through a semi-permeable membrane. After oral administration, taxifolin and its five metabolites were identified in rat plasma by ultra high performance liquid chromatography (UPLC) with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). The dynamic variation of taxifolin and its metabolites in plasma were then quantified by UPLC with a triple-quadrupole typemass spectroscopy (UPLC-QqQ-MS/MS). A pharmacokinetic study showed that the bioavailability of taxifolin increased from 0.35% to 0.52% through TZP fabrication. The plasma concentration of taxifolin glucuronide and methylated taxifolin glucuronide was much higher than taxifolin. Glucuronidation was the dominating metabolism pathway of taxifolin in vivo.

Keywords: Characterization, Bioavailability, Taxifolin, Zein nanoparticles

References(38)

[1]

S. Zu, L. Yang, J. Huang, et al., Micronization of taxifolin by supercritical antisolvent process and evaluation of radical scavenging activity, Int. J. Mol. Sci. 13 (2012) 8869-8881. http://doi.org/10.3390/ijms13078869.

[2]

B. Abad-García, S. Garmón-Lobato, L.A. Berrueta, et al., A fragmentation study of dihydroquercetin using triple quadrupole mass spectrometry and its application for identification of dihydroflavonols in Citrus juices, Rapid Commun. Mass Spectrom. 23 (2019) 2785-2792. http://doi.org/10.1002/rcm.4182.

[3]

D. Turck, J. Bresson, B. Burlingame, et al., Scientific opinion on taxifolin-rich extract from Dahurian Larch (Larix gmelinii), EFSA J. 15 (2017) e04682. http://doi.org/10.2903/j.efsa.2017.4682.

[4]

C. Sunil, B. Xu, An insight into the health-promoting effects of taxifolin (dihydroquercetin), Phytochemistry 166 (2019) 112066. http://doi.org/10.1016/j.phytochem.2019.112066.

[5]

A.E. Weidmann, Dihydroquercetin: More than just an impurity? Eur. J. Pharmacol. 684 (2012) 19-26. http://doi.org/10.1016/j.ejphar.2012.03.035.

[6]

A. Das, R. Baidya, T. Chakraborty, et al., Pharmacological basis and new insights of taxifolin: a comprehensive review, Biomed. Pharmacother. 142 (2021) 112004. https://doi.org/10.1016/j.biopha.2021.112004.

[7]

F.C. Stenger Moura, N. Pinna, R. Vivani, et al., Exploring taxifolin polymorphs: insights on hydrate and anhydrous forms, Pharmaceutics 13 (2021) 1328. https://doi.org/10.3390/pharmaceutics13091328.

[8]

X.D. Wang, M.X. Meng, L.B. Gao, et al., Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp, Int. J. Pharm. 378 (2009) 1-8. http://doi.org/10.1016/j.ijpharm.2009.05.022.

[9]

X. Wang, H. Xia, F. Xing, et al., A highly sensitive and robust UPLC-MS with electrospray ionization method for quantitation of taxifolin in rat plasma, J. Chromatogr. B. 877 (2009) 1778-1786. http://doi.org/10.1016/j.jchromb.2009.04.037.

[10]

C.J. Yang, Z.B. Wang, Y.Y. Mi, et al., UHPLC-MS/MS determination, pharmacokinetic, and bioavailability study of taxifolin in rat plasma after oral administration of its nanodispersion, Molecules 21 (2016) 494. http://doi.org/10.3390/molecules21040494.

[11]

O.N. Pozharitskaya, M.V. Karlina, A.N. Shikov, et al., Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography, Phytomedicine 16 (2009) 244-251. http://doi.org/10.1016/j.phymed.2008.10.002.

[12]

A.N. Shikov, O.N. Pozharitskaya, I. Miroshnyk, et al., Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior, Int. J. Pharm. 377 (2009) 148-152. http://doi.org/10.1016/j.ijpharm.2009.04.044.

[13]

M.V. Karlina, O.N. Pozharitskaya, A.N. Shikov, Development and in vitro biopharmaceutical evaluation of a dihydroquercetin microemulsion. Pharm. Chem. J. 43 (2009) 352. https://doi.org/10.1007/s11094-009-0308-x.

[14]

F. Hasibi, A. Nasirpour, J. Varshosaz, et al., Formulation and characterization of taxifolin-loaded lipid nanovesicles (liposomes, niosomes, and transfersomes) for beverage fortification, Eur. J. Lipid Sci. Technol. 122 (2020) 1900105. https://doi.org/10.1002/ejlt.201900105.

[15]

J.M. Irache, C.J. González-Navarro, Zein nanoparticles as vehicles for oral delivery purposes, Nanomedicine 12 (2017) 1209-1211. 10.2217/nnm-2017-0075.

[16]

Y. Luo, Q. Wang, Zein-based micro-and nano-particles for drug and nutrient delivery: a review, J. Appl. Polym. Sci. 131 (2014) 1107-1117. http://doi.org/10.1002/app.40696.

[17]

T. Zou, L. Gu, TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance, Mol. Pharmaceutics 10 (2013) 2062-2070. http://doi.org/10.1021/mp400086n.

[18]

D. Zheng, Q.F. Zhang, Bioavailability enhancement of astilbin in rats through zein-caseinate nanoparticles, J. Agric. Food Chem. 67 (2019) 5746-5753. http://doi.org/10.1021/acs.jafc.9b00018.

[19]

C.C. Sun, H. Su, G.D. Zheng, et al., Fabrication and characterization of dihydromyricetin encapsulated zein-caseinate nanoparticles and its bioavailability in rat, Food Chem. 330 (2020) 127245. http://doi.org/10.1016/j.foodchem.2020.127245.

[20]

X.L. Qiu, Q.F. Zhang, Acidic hydrolysis of astilbin and its application for the preparation of taxifolin from Rhizoma Smilacis Glabrae, J. Chem. Res. 45 (2021) 290-294. http://doi.org/10.1177/1747519820948357.

[21]

United States Pharmacopeia, Simulated gastric fluid and simulated intestinal fluid, TS. The United States Pharmacopeia, 23, The National Formularly (1995) 2207-2235.

[22]

Q.F. Zhang, Y.J. Fu, Z.W. Huang, et al., Aqueous stability of astilbin: effects of pH, temperature, and solvent, J. Agric. Food Chem. 61 (2013) 12085-12091. http://doi.org/10.1021/jf404420s.

[23]

D. Zheng, C.C. Sun, H. Su, et al., Metabolism, excretion, and tissue distribution of astilbin-zein nanoparticles in rats, J. Agric. Food Chem. 67 (2019) 8332-8338. http://doi.org/10.1021/acs.jafc.9b02569.

[24]

A.R. Patel, E.C. Bouwens, K.P. Velikov, Sodium caseinate stabilized zein colloidal particles, J. Agric. Food Chem. 58 (2010) 12497-12503. http://doi.org/10.1021/jf102959b.

[25]

C. Chang, T. Wang, Q. Hu, et al., Caseinate-zein-polysaccharide complex nanoparticles as potential oral delivery vehicles for curcumin: effect of polysaccharide type and chemical cross-linking, Food Hydrocoll. 72 (2017) 254-262. http://doi.org/10.1016/j.foodhyd.2017.05.039.

[26]

L. Dai, C. Sun, R. Li, et al., Structural characterization, formation mechanism and stability of curcumin in zein-lecithin composite nanoparticles fabricated by antisolvent co-precipitation, Food Chem. 237 (2017) 1163-1171. https://doi.org/10.1016/j.foodchem.2017.05.134.

[27]

A.R. Patel, P.C. Heussen, J. Hazekamp, et al., Quercetin loaded biopolymeric colloidal particles prepared by simultaneous precipitation of quercetin with hydrophobic protein in aqueous medium, Food Chem. 133 (2012) 423-429. https://doi.org/10.1016/j.foodchem.2012.01.054.

[28]

Z. Li, H. Jiang, C. Xu, et al., A review: using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals, Food Hydrocoll. 43 (2015) 153-164. http://doi.org/10.1016/j.foodhyd.2014.05.010.

[29]

G. Williamson, C.D. Kay, A. Crozier, The bioavailability, transport, and bioactivity of dietary flavonoids: a review from a historical perspective, Compr. Rev. Food Sci. F. 17 (2018) 1054-1112. http://doi.org/10.1111/1541-4337.12351.

[30]

S.H. Thilakarathna, H.P. Rupasinghe, Flavonoid bioavailability and attempts for bioavailability enhancement, Nutrients 5 (2013) 3367-3387. http://doi.org/10.3390/nu5093367.

[31]

P. Yang, F. Xu, H.F. Li, et al., Detection of 191 taxifolin metabolites and their distribution in rats using HPLC-ESI-IT-TOF-MSn, Molecules 21 (2016) 1209. http://doi.org/10.3390/molecules21091209.

[32]

B. Ge, L. Zhao, X. Li, et al., Glucuronidation is the dominating in vivo metabolism pathway of herbacetin: elucidation of herbacetin pharmacokinetics after intravenous and oral administration in rats, J. Funct. Foods 40 (2018) 659-669. http://doi.org/10.1016/j.jff.2017.12.006.

[33]

A. Crozier, I.B. Jaganath, M.N. Clifford, Dietary phenolics: chemistry, bioavailability and effects on health, Nat. Prod. Rep. 26 (2009) 1001-1043. http://doi.org/10.1039/b802662a.

[34]

X.J. Tian, X.W. Yang, X. Yang, et al., Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int. J. Pharm. 367 (2009) 58-64. http://doi.org/10.1016/j.ijpharm.2008.09.023.

[35]

M. Hu, Commentary: bioavailability of flavonoids and polyphenols: call to arms, Mol. Pharmaceutics 4 (2007) 803-806. http://doi.org/10.1021/mp7001363.

[36]

J.M. Landete, Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health, Rev. Food Sci. Nutr. 52 (2012) 936-948. http://doi.org/10.1080/10408398.2010.513779.

[37]

A.M. Nectoux, C. Abe, S.W. Huang, et al., Absorption and metabolic behavior of hesperidin (Rutinosylated Hesperetin) after single oral administration to sprague-dawley rats, J. Agric. Food Chem. 67 (2019) 9812-9819. http://doi.org/10.1021/acs.jafc.9b03594.

[38]

A.J. Day, F. Mellon, D. Barron, et al., Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin, Free Radical Res. 35 (2001) 941-952. http://doi.org/10.1080/10715760100301441.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 16 September 2021
Revised: 30 October 2021
Accepted: 29 November 2021
Published: 04 April 2023
Issue date: November 2023

Copyright

© 2023 Beijing Academy of Food Sciences.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (32060541).

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return